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Background: We sought to determine the comparative diagnostic performance of standard b-value (800–1000 s/mm2)
versus low b-value (400–500 s/mm2) diffusion-weighted magnetic resonance imaging (DW-MRI) in the detection of
renal cell carcinoma (RCC).
Method: After a systematic review of the available literature, studies were included that reported b-values, used a
histopathological reference standard, and allowed construction of 2 × 2 contingency tables for detection of RCC
lesions using DW-MRI. In addition, a summary receiver operating characteristic (SROC) analysis was performed.
Results: Four articles that complied with all inclusion and exclusion criteria were selected for data extraction and
analysis (n = 248 lesions in 266 patients). All four studies were high quality. Standard b-value DW-MRI displayed a
pooled sensitivity of 0.59 (95% confidence interval (CI): 0.51-0.67) and a pooled specificity of 0.50 (95% CI: 0.30-0.70),
while low b-value DW-MRI displayed a pooled sensitivity of 0.58 (95% CI: 0.48-0.63) and a pooled specificity of 0.23
(95% CI: 0.09-0.44). The SROC curve of standard b-value DW-MRI displayed an AUC of 0.61 and a Q*index of 0.59, while
the SROC curve of low b-value DW-MRI displayed an AUC of 0.68 and a Q*index of 0.64.
Conclusion: Standard b-value DW-MRI showed a superior specificity but an approximately equivalent sensitivity to low
b-value DW-MRI in detecting RCC lesions in the kidney. However, low b-value DW-MRI displayed an overall superior
diagnostic accuracy over standard b-value DW-MRI.
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Renal cell carcinoma (RCC) is the most common form
of adult renal cancer, accounting for 85-90% of kidney
neoplasms and ~3% of adult malignancies [1]. Unfortu-
nately, many RCC tumors are asymptomatic and non-
palpable in their early stages; therefore, greater than 50%
of RCC tumors are incidentally detected by diagnostic
imaging [2]. Due to a paucity of effective screening tests,
approximately a third of RCC patients present with me-
tastasis at the time of diagnosis. Moreover, 30-50% of
kidney-localized RCC eventually metastasize with a me-
dian survival of 10.2 months and a five-year survival rate
under 15% [3,4].* Correspondence: tyl0871@163.com
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unless otherwise stated.Currently, renal lesions are evaluated using contrast-
enhanced computed tomography (CT) and magnetic
resonance imaging (MRI). False-negative interpretations
occur when imaging necrotic or cystic malignant renal
lesions that can be mistakenly interpreted as complex
renal cysts due to a lack of enhancement [5,6]. More-
over, contrast-enhanced studies are typically precluded
in patients who have renal impairment or allergies to
contrast agents [7]. These clinical limitations have led to
the use of other imaging modalities, such as diffusion-
weighted MRI (DW-MRI), which provide both qualita-
tive and quantitative tissue characterization without the
need for contrast enhancement.
DW-MRI functions by visualizing the random (Brownian)
motion of water molecules within tissues [8]. Specifically,
motion probing gradients are applied to non-directionally
sensitize water molecules in order to determine waterd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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If water moves substantially between diffusion-sensitizing
gradients, the resulting bulk water signal is low; however, if
water is restricted from moving between these gradients,
the signal is high [9]. The diffusion gradient strength is
termed the b-value [s/mm2] and is dependent on the dur-
ation and amplitude of the diffusion sensitizing gradient as
well as the time between applications of the sensitizing gra-
dient; therefore, in order to increase the b-value during
DW-MRI, a greater amplitude of the diffusion-sensitizing
gradient is typically applied [9].
Through linear regression, images taken at various b-
values can then be used to calculate the apparent diffu-
sion coefficient (ADC) in a particular region of interest.
With respect to focal renal lesions, solid malignancies
typically display lower ADC values than benign lesions,
possibly related to the high cellular density of tumors
with intact cell membranes that impedes the Brownian
motion of water molecules. One meta-analysis of 17
studies has demonstrated that ADC values can help dis-
tinguish between benign and malignant RCC tumors
with RCC tumors displaying significantly lower ADC
values than benign kidney tissue [8].
Although ADC values of RCC tumors have been well-
analyzed by previous studies, no study has yet examined
the b-values of DW-MRI with respect to RCC. This is of
clinical importance, as factors aside from passive diffusion,
such as capillary perfusion, can contribute to decreased
signal-to-noise ratio (SNR) in low b-value DW-MRI [10].
On account of this signal decay, low b-value DW-MRI be-
comes less qualitative and more quantitative, since it must
be based on complex ADC calculations. Therefore, as low
b-value DW-MRI does not facilitate qualitative detection
of malignancies which may adversely affect diagnostic ac-
curacy, the objective of this study was to determine the
comparative diagnostic performance of standard b-value
(800–1000 s/mm2) versus low b-value (400–500 s/mm2)
DW-MRI in the detection of RCC.
Methods
Ethics statement
All data were extracted from previously published stud-
ies. We merged these data to perform the meta-analysis
as follows.
Search strategy
A systematic review of the available literature was per-
formed according to the PRISMA (preferred reporting
items for systematic reviews and meta-analyses) guide-
lines [11]. Relevant randomized controlled trials (RCTs)
were identified from systematic searches of several major
electronic databases (MEDLINE via PubMed, EMBASE,
and the Cochrane Central Register of Controlled Trials via
Ovid) up to November 2013 with different combinationsof the following key words: (“diffusion-weighted” OR
“DWI”) AND (“magnetic resonance imaging” OR “MRI”)
AND (“ADC” OR “apparent diffusion coefficient”) AND
(“renal cell carcinoma” OR “RCC” OR “renal carcinoma”
OR “renal cancer” OR “kidney cancer”). Additional rele-
vant articles were obtained by scanning conference sum-
maries and article reference lists identified in the initial
searches. An English language restriction was imposed.
Inclusion and exclusion criteria
Studies were selected for inclusion on the basis of the
following criteria: assessing of the diagnostic perform-
ance of DW-MRI in evaluating RCC; providing histo-
pathological results; providing b-values and ADC values;
presenting sufficient information to calculate the true-
positive (TP), false-positive (FP), true-negative (TN), and
false-negative (FN) values for construction of 2 × 2 con-
tingency tables. Studies were excluded on the basis of
the following criteria: the same study population was
assessed in more than one publication (in this case, the
publication with the most details and/or the most recent
publication date was chosen); the performance assessment
of DW-MRI alone could not be extracted; or the articles
are reviews, editorials, commentaries, or case reports.
Study selection and data extraction
The titles and abstracts of studies identified by the
search strategy were independently screened by two re-
viewers, and clearly irrelevant studies were discarded.
The full texts were obtained from all articles which met
the inclusion criteria. Then, the articles were scanned
and the data from these studies were extracted, includ-
ing: first author's name, year of publication, study design,
number of patients per arm, total number of lesions im-
aged, reference or gold standard (e.g., whole-mount or
step-section histopathology, biopsy), coil type (e.g., torso
surface phased-array, endorectal, body coil), field strength
(e.g., 1.5 T, 3.0 T), b-value, and TP, FP, TN, and FN values
for construction of 2 × 2 contingency tables. Disagree-
ments between the two reviewers were resolved by major-
ity opinion after a third reviewer assessed all involved
items.
Quality assessment
The methodological quality of the included studies was
assessed by two independent observers using the Quality
Assessment of Diagnostic Studies (QUADAS) instru-
ment specifically developed for systematic reviews of
diagnostic test accuracy [12].
Meta-analysis
Data were analyzed using Meta-Disc (version 1.4) soft-
ware [13,14]. We pooled the data with the DerSimonian-
Laird random effects model (REM) [15-17]. This REM
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dence intervals, as it assumes that the meta-analysis in-
cludes only a sample of all possible studies [18,19]. In
addition, this REM accounts for both within-study vari-
ability (random error) and between-study variability
(heterogeneity). We used Chi-square analysis to detect
heterogeneity in the summary results.
Each study in the meta-analysis contributed data to
form 2 × 2 contingency tables to determine sensitivity
and specificity [20,21]. We then performed a summary
receiver operating characteristic (SROC) curve analysis.
The SROC displays a study's estimated sensitivity and
specificity within the ROC space. A regression curve is
then fitted through the distribution of sensitivity and
specificity pairs. A shoulder-like curve reveals that the
inter-study variability may be due to a threshold effect,
while a non-shoulder-like curve indicates that sensitivity
and specificity are not correlated [19,22]. The area under
the SROC curve (AUC) demonstrates the trade-off be-
tween specificity and sensitivity, showing the overall
summary of diagnostic performance with an AUC of 1.0
(100%) indicating a perfectly discriminating test [23]. In
addition, we calculated the Q* index – defined by the
point where sensitivity equates to specificity on the SROC
curve – as a global estimate of diagnostic accuracy to en-
able comparison of SROC curves with a Q* value of 1.0
indicating 100% sensitivity and 100% specificity [24,25].
Results
After the initial computer search, manual crosschecking
of reference lists, and elimination of duplicate records,
51 unique records were identified (Figure 1). Next, the
titles and abstracts were reviewed, resulting in 13 eligible
full-text articles. After reviewing the 13 full-text articles,
we excluded 9 relevant articles for various reasons de-
scribed in Figure 1. The remaining four articles compliedFigure 1 Flow diagram of study selection.with all inclusion and exclusion criteria and were se-
lected for data extraction and data analysis (Table 1)
[26-29]. According to QUADAS assessment, all four
studies were of high quality (Table 2).
A total of 248 lesions in 266 patients were used in this
meta-analysis. The reference standard in all four studies
was histopathology. The random effects model was used
in all cases. The number of publications was sufficient to
run the random effects model in all cases.
Standard b-value (800–1000 s/mm2) DW-MRI dis-
played a sensitivity of 0.59 (95% confidence interval (CI):
0.51-0.67) and a specificity of 0.50 (95% CI: 0.30-0.70) in de-
tecting RCC (Figure 2), while low b-value (400–500 s/mm2)
DW-MRI displayed a sensitivity of 0.58 (95% CI: 0.48-0.63)
and a specificity of 0.23 (95% CI: 0.09-0.44) in detecting
RCC (Figure 3). For the standard b-value analysis, the
chi-square values for the sensitivity, specificity, positive
likelihood ratio, negative likelihood ratio, and diagnos-
tic odds ratio were 0%, 84.8%, 76.5%, 68.9%, and 66.3%,
respectively; thus, the heterogeneity in the standard b-
value analysis was high. For the low b-value analysis,
the chi-square values for the sensitivity, specificity,
positive likelihood ratio, negative likelihood ratio, and
diagnostic odds ratio were 0%, 32.4%, 15.6%, 0%, and
0%, respectively; thus, the heterogeneity in the low b-value
analysis was low. The SROC curve of standard b-value
DW-MRI displayed an AUC of 0.61 and a Q*index of
0.59, while the SROC curve of low b-value DW-MRI dis-
played an AUC of 0.68 and a Q*index of 0.64 (Figure 4).
Discussion
On account of signal decay, low b-value DW-MRI can-
not be qualitative in nature but must be quantitatively
based on complex calculations of ADC values [10]. On
the other hand, higher b-value DW-MRI typically uses
an acquisition method with multiple excitations to
Table 1 Characteristics of included studies










Wang 2010 [25] Retrospective 83 85 Histopathology Surface phased-array coil 3.0 500, 800
Rosenkrantz 2010 [24] Retrospective 57 57 Histopathology Torso phased-array coil 1.5 400, 800
Chandarana 2012 [28] Prospective 26 26 Histopathology Torso phased-array coil 1.5 1000
Goyal 2013 [29] Retrospective 100 80 Histopathology Phased-array body coil 1.5 500
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count of its reflection of more tissue diffusivity and less
T2 shinethrough effect [14,30]. Although the multiple
excitations applied in higher b-value DW-MRI can pro-
duce increases in motion artifacts, these artifacts are av-
eraged over the multiple excitations by motion-probing
gradients and become inconspicuous in the recon-
structed images. Thus, with increasing b-values, better
qualitative images with a superior SNR are achieved while
sacrificing quantitative absolute ADC values that become
impossible to calculate on account of signal averaging.
In this study, standard b-value DW-MRI (800–
1000 s/mm2) showed a superior specificity (0.50 vs. 0.23)
but an approximately equivalent sensitivity (0.59 vs. 0.58)
to low b-value DW-MRI (400–500 s/mm2) in detecting
RCC lesions in the kidney (Figures 2, 3). However, low
b-value DW-MRI displayed an overall superior diagnostic
accuracy over standard b-value DW-MRI as measured by
their respective SROC curves (AUC: 0.68 vs. 0.62; Q*
index: 0.64 vs. 0.59) in detecting RCC lesions in the kidneyTable 2 Methodological quality of included studies
Item
Was the spectrum of patients clearly representative of the patients who will
practice?
Were selection criteria clearly described?
Is the reference standard likely to correctly classify the target condition?
Is the time period between reference standard and index test short enough
sure that the target condition did not change between the two tests?
Did the whole sample or a random selection of the sample receive verification
standard of diagnosis?
Did patients receive the same reference standard regardless of the index tes
Was the reference standard independent of the index test (i.e. the index test
of the reference standard)?
Was the execution of the index test described in sufficient detail to permit repli
Was the execution of the reference standard described in sufficient detail to pe
Were the index test results interpreted without knowledge of the results of the
Were the reference standard results interpreted without knowledge of the resu
Were the same clinical data available when test results were interpreted as w
when the test is used in practice?
Were missing data on the index test handled correctly?
Were withdrawals from the study explained?
Abbreviations: Y yes, N no, U unclear.(Figure 4). Although this study exclusively focused on
the effects of varying b-values on the diagnostic accur-
acy of detecting RCC lesions in the kidney, two previous
studies have examined varying b-values in differentiating
malignant from benign renal lesions in the aggregate (i.e.,
not specifically RCC lesions). In contrast to our findings,
Doganay et al. and Erbay et al. collected diffusion data
across multiple b-values in patients with various renal
mass pathologies and demonstrated that detection of ma-
lignant renal lesions improves at b-values of greater than
600 s/mm2 [31,32]. These findings suggest that optimal
b-values vary across different types of renal lesions;
thus, future studies should focus on determining the
optimal b-values on a renal tumor-specific basis.
RCC tumors are unique due to the presence of hemo-
siderin deposits, a phenomenon which has proven useful
in their differentiation from other tumor types [32,33].
According to a recent study by Childs et al., the para-
magnetic effect of hemosiderin is likely responsible for








receive the test in Y Y Y Y
Y Y Y Y
Y Y Y Y
to be reasonably Y Y U U
using a reference Y Y Y N
t result? Y Y Y Y
did not form part Y Y Y Y
cation of the test? Y Y Y Y
rmit its replication? Y Y Y Y
reference standard? Y Y Y Y
lts of the index test? Y Y U U
ould be available Y Y Y Y
Y Y Y Y
Y Y Y Y
Figure 2 Forest plots of sensitivity and specificity estimates for standard b-value DW-MRI in detecting renal cell carcinoma. Point
estimates of (A) sensitivity and (B) specificity from each study are shown as solid red circles. The solid blue lines represent the 95% confidence
intervals (CI). Circles are proportional to study size. The pooled estimates are denoted by the red diamonds at the bottom.
Figure 3 Forest plots of sensitivity and specificity estimates for low b-value DW-MRI in detecting renal cell carcinoma. Point estimates
of (A) sensitivity and (B) specificity from each study are shown as solid red circles. The solid blue lines represent the 95% confidence intervals (CI).
Circles are proportional to study size. The pooled estimates are denoted by the red diamonds at the bottom.
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Figure 4 Summary receiving operating characteristic plot with best-fitting asymmetric curve for standard and low b-value DW-MRI in
detecting renal cell carcinoma. Summary receiving operating characteristic (SROC) plot with best-fitting asymmetric curve for (A) standard and
(B) low b-value DW-MRI. Each solid red circle represents each study in the meta-analysis. The blue curve is the regression line that summarizes
the overall diagnostic accuracy. SROC = summary receiver operating characteristic; AUC = area under the curve; SE(AUC) = standard error of AUC;
Q* = an index defined by the point on the SROC curve where the sensitivity and specificity are equal, which is the point closest to the top-left
corner of the ROC space; SE(Q*) = standard error of Q* index.
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local magnetic susceptibility-induced intravoxel dephasing
is important to DW-MRI of RCC lesions since a greater
degree of intravoxel dephasing results in greater loss of
signal intensity [31]. This phenomenon may contribute to
the limited sensitivity of DW-MRI for the diagnosis of ma-
lignant renal masses observed here (i.e., 0.59 for standard
b-value DW-MRI and 0.58 for low b-value DW-MRI).
Raising the b-value increases the degree of diffusion
weighting (i.e., increases the signal loss caused by the dif-
fusion of water molecules along the direction of the ap-
plied gradient), which increases the contrast between
tissues with different diffusion coefficients while also de-
creasing the overall signal intensity and SNR [34]. Thus,
the underlying loss of signal intensity from hemosiderin-
induced intravoxel dephasing combined with the loss of
signal intensity from applying a higher b-value may ex-
plain why standard b-value DW-MRI displayed an overall
inferior diagnostic accuracy over low b-value DW-MRI in
detecting RCC lesions here (AUC of 0.62 for standard b-
value DW-MRI vs. 0.68 for low b-value DW-MRI).
There also have been numerous studies that have ex-
amined the effect of varying b-values on the diagnostic
accuracy of detecting malignant lesions in other abdom-
inal tissues. For example, Wu et al. analyzed DW-MRI
in combination with conventional MRI and found that a
b-value of 1500 s/mm2 significantly improved the speci-
ficity, but not the sensitivity, in diagnosing upper urinary
tract cancer compared to a b-value of 500 s/mm2 [34].
Koc et al. found that DW-MRI with b-values of 600 s/mm2
and higher can better differentiate benign and malignant
abdominal and gynecological lesions [33,35]. Bozcurt et al.
analyzed DW-MRI in combination with conventional MRI
and found that a b-value of 800 s/mm2 increased specifi-
city with no significant affect on sensitivity and accuracy in
diagnosing peritoneal tumors compared to a b-value of
400 s/mm2 [36]. Goshima et al. demonstrated that a b-
value of 100 s/mm2 possesses a higher sensitivity for malig-
nant hepatocellular carcinoma lesions as compared to
higher b-values (i.e., 200, 400, and 800 s/mm2) but demon-
strated comparable specificities across all b-values [37].
These studies indicate that varying b-values can signifi-
cantly affect the diagnostic accuracy of DW-MRI's detec-
tion of malignant lesions; however, there is no clear trend
favoring high or low b-values across different tissue and
tumor types. Therefore, further studies are required to de-
termine the optimal b-values on a tissue-specific and
tumor-specific basis.
This meta-analysis has several limitations. First, the
number of included studies was relatively small. Second,
three included studies only included clear cell RCC cases
(the most common RCC variant accounting for 70% of
cases in surgical series) [38], while one study (Wang
2010) included cases of both clear cell and non-clear cellRCC, which may have adversely affected the meta-
analysis. Third, this meta-analysis included negative
cases but did not include other types of renal tumors or
benign kidney conditions. Thus, the specificity reported
here should be considered relative rather than absolute.
Fourth, we did not evaluate metastasis here; our sole
purpose was to evaluate the diagnostic ability of stand-
ard versus low b-value DW-MRI in detecting kidney
RCC lesions. Fourth, as no study with a b-value of
greater than 1000 s/mm2 was included here, further trials
in RCC patients are needed to determine whether increas-
ing b-values beyond 1000 s/mm2 affects the diagnostic ac-
curacy of detecting RCC lesions in kidney tissue.
Conclusion
Standard b-value DW-MRI showed a superior specificity
but an approximately equivalent sensitivity to low b-value
DW-MRI in detecting RCC lesions in the kidney. How-
ever, low b-value DW-MRI displayed an overall superior
diagnostic accuracy over standard b-value DW-MRI in de-
tecting RCC lesions in the kidney. Further studies that ad-
dress the limitations discussed herein are needed to
support our findings.
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